Nutritional Recommendations For Individuals Affected By Coronavirus Disease 2019

Exponential spread of COVID-19 pandemic has affected the entire world and caused acollapse in health systems to, due to the short contagion time, the need for hospitalization and intensive care. Of the affected, some portion needs hospitalization and essential nutritional support. Considering the current demand on the need to better inform and prepare health professionals and the general population in a simplified mode, given a huge amount of disseminated information, the objective of this work was to present a summarized and practical guide of references and nutritional recommendations for individuals affected by COVID-19. Bibliographic review about this subject related publications was carried out on scientific websites, including the main themes: critical patient, nutritional status, nutritional recommendations, immunity and coronavirus. The following items were included and presented in this guide: screening for nutritional risk; administration routes, objectives and guidelines of nutritional therapy; dietary and nutritional recommendations; immunomodulation; probiotics; and liquids/hydration.

CORONAVIRUS DISEASE 2019 (COVID-19) CORONAVIRUS DISEASE 2019 (COVID-19) Provides comprehensive coverage of all key aspects of COVID-19, including: etiology, diagnosis, symptomatology, management, and treatment Coronavirus Disease 2019 (COVID-19): A Clinical Guide provides healthcare professionals at all levels with up-to-date knowledge about the clinical, epidemiological, genomic, virological, and radiologic features of COVID-19. Consolidating multiple systematic reviews and meta-analyses into a single volume, this comprehensive textbook also addresses health policies, mass casualty planning, healthcare worker safety, economic impact, lessons for future outbreaks, and other para-clinical and social aspects of the COVID-19 pandemic. The text presents a thorough summary and critical analysis of COVID-19 based on an exhaustive review of recently published literature and data. Topics include the virologic characteristics of SARS-CoV-2, pulmonary and extrapulmonary manifestations and consequences of COVID-19, prevention and transmission control, the pandemic’s indirect impact to the care and management of other diseases, passive immunotherapy and its implications, diagnostic and treatment approaches for critically ill patients, and more. Edited by leading ­practitioners at the forefront of COVID-19 research, this invaluable resource: Integrates clinical, radiological, and epidemiological data and discussion of prevention, diagnosis, and treatment Reviews the epidemiology, mechanisms of action, manifestations, and management of cardiovascular, neurological, and pulmonary diseases associated with COVID-19 Covers diagnostic technologies, includes radiologic imaging, and RT-PCR testing Explores therapeutic approaches for managing a variety of complications Discusses post-vaccination symptom management and implications of immunization Addresses COVID-19 in pediatrics, in cancer patients, and in patients with lung disease, diabetes, ­hypertension, obesity, and other underlying conditions Coronavirus Disease 2019 (COVID-19): A Clinical Guide is an indispensable source of information for all clinicians, researchers, epidemiologists, nurses, radiologists, and healthcare managers working to address any aspect of the COVID-19 pandemic.

In December 2019, the world witnessed the occurrence of a new coronavirus to humanity. The disease spread quickly and became known as a pandemic globally, affecting both society and the health care system, both the elderly and young groups of people, and both the men’s and women’s groups. It was a universal challenge that immediately caused a surge in scientific research. Be a part of a world rising in fighting against the pandemic, the Coronavirus Disease - COVID-19 was depicted in the early days of the pandemic, but updated by more than 200 scientists and clinicians to include many facets of this new infectious pandemic, including i, characteristics, ecology, and evolution of coronaviruses; ii, epidemiology, genetics, and pathogenesis (immune responses and oxidative stress) of the disease; iii, diagnosis, prognosis, and clinical manifestations of the disease in pediatrics, geriatrics, pregnant women, and neonates; iv, challenges of co-occurring the disease with tropical infections, cardiovascular diseases, hypertension, and cancer and to the settings of dentistry, hematology, ophthalmology, and pharmacy; v, transmission, prevention, and potential treatments, ranging from supportive ventilator support and nutrition therapy to potential virus- and host-based therapies, immune-based therapies, photobiomodulation, antiviral photodynamic therapy, and vaccines; vi, the resulting consequences on social lives, mental health, education, tourism industry and economy; and vii, multimodal approaches to solve the problem by bioinformatic methods, innovation and ingenuity, globalization, social and scientific networking, interdisciplinary approaches, and art integration. We are approaching December 2020 and the still presence of COVID-19, asking us to call it COVID (without 19).

The principle of equality is the ideological basis for the public healthcare system in most Western countries. Equality in availability of and access to healthcare services is an essential condition for fulfilling the “patient-centered” perspective that prevails today in many healthcare systems around the world. Equality in health, in its various aspects, is a value to which many aspire, although some extent of inequality and health will always exist. Since some disparities in health are unavoidable and individuals are free to live as they wish, there will always be gaps among population groups in their abilities and willingness to invest in their health.